Precigen reports second quarter / first half 2024 financial results and business updates. View press release and join our conference call today at 4:30pm ET: https://bit.ly/3yGJAae
Precigen
Biotechnology Research
Germantown, Maryland 5,117 followers
Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of gene and cell therapies.
Über uns
Precigen: Advancing Medicine with Precision™ Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
- Website
-
http://www.precigen.com
External link for Precigen
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 201-500 Mitarbeiter
- Hauptsitz
- Germantown, Maryland
- Typ
- Öffentliches Unternehmen
- Spezialitäten
- Gene Therapy and Cell Therapy
Standorte
-
Primäre
20358 Seneca Meadows Pkwy
Germantown, Maryland 20876, US
Employees at Precigen
Aktualisierungen
-
Join Precigen on Wednesday, August 14, 2024 at 4:30 PM ET for a conference call to discuss second quarter and first half 2024 financial results. View details: https://bit.ly/3LqNK9i
-
-
#ICYMI: Watch the replay of the webcast from #RRPAwarenessDay held on June 11, 2024 at the National Press Club in Washington, DC. We are so thankful to the patient and caregiver panelists for sharing their stories and bringing insights and hope to others, to National Cancer Institute (NCI) panelists for their dedication and tenacity in finding new treatment options for RRP patients, to Senator Mark Warner of Virginia for fighting for the rare disease community, and for Gov. Wes Moore of Maryland for supporting the RRP community and sharing his own family's experience with rare disease. A special thank you to our co-hosts at the RECURRENT RESPIRATORY PAPILLOMATOSIS FOUNDATION for everything you do for the RRP community, including co-creating this special awareness day and the associated event. We look forward to continuing our collaboration and #GivingVoicetoInspireChange for the RRP community. Watch the replay and checkout photos from the event at https://rrpawareness.org
-
-
We are incredibly grateful and inspired by the turnout for our inaugural #RRPAwarenessDay. People with RRP, caregivers, clinicians, researchers and industry innovators shared their inspiring stories and messages with the rare disease community. To the hundreds who participated at the National Press Club and via webcast, thank you! Together, we are shaping a hopeful and positive future for those impacted by RRP. We would like to extend our deepest gratitude to the RECURRENT RESPIRATORY PAPILLOMATOSIS FOUNDATION for its dedication to building a community among those affected by this devastating disease. Watch the #RRPAwarenessDay co-hosts share their thoughts on what they hope we achieved for RRP patients today. #RRPAwareness #GivingVoicetoInspireChange
-
Only 1 week to go until RRP Awareness Day, a multi-stakeholder event to raise awareness and bring together individuals living with RRP, caregivers, clinicians, and government officials. View details at http://rrpawareness.org and join us!
Startseite
https://rrpawareness.org
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Letzte Runde
Eigenkapital nach dem IPOUS$ 30.0M